Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
about
Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosisChondroitin sulfate proteoglycans in the nervous system: inhibitors to repairPrimary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammationTherapeutic neuroprotective agents for amyotrophic lateral sclerosisSerine racemase: a key player in apoptosis and necrosisA perspective on stem cell modeling of amyotrophic lateral sclerosisReduction of circulating endothelial cells in peripheral blood of ALS patientsTranslational research involving oxidative stress and diseases of aging.Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates.Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose.Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosisDeregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model.Inflammation in ALS and SMA: sorting out the good from the evil.Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.Expression of a pathogenic mutation of SOD1 sensitizes aprataxin-deficient cells and mice to oxidative stress and triggers hallmarks of premature ageing.Progress in therapy development for amyotrophic lateral sclerosisActivation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of InflammationMolecular and cellular pathways of neurodegeneration in motor neurone diseaseDeath Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis.Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis.Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord.Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression.Current and future directions in genomics of amyotrophic lateral sclerosis.Use of biomarkers in ALS drug development and clinical trialsIntraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.Antioxidants in central nervous system diseases: preclinical promise and translational challenges.Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trialT cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytesGlial cells in amyotrophic lateral sclerosisEndothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier RepairCardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse ModelProximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to NeurodegenerationFormation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene.
P2860
Q21245232-484FA738-6D9A-4EF9-AB6B-214498EF473BQ21284516-2E9E766C-F1EC-41B8-A115-0A55A000BF78Q25256714-A8657E66-6598-4D24-A56D-8B4441E901B6Q27015029-09F31EF3-44DA-4008-BADB-50AC811C8F35Q27025560-309202F4-DF61-4CCF-8F53-D9D72220AA59Q28080614-28C6A729-C48B-4CB6-A07C-AE33B2509235Q28752226-180BB178-D60A-4898-B1BE-5059B93E3C42Q30464085-CA43FFAF-280C-438C-83E8-C44F479ACAB1Q30668718-319B7F0F-293D-4DBD-8F84-66D304564868Q33346297-DA12A35E-6584-4378-8954-8741DEE08D5CQ33500473-57D71A8B-9096-4097-8EDB-B5993277F57CQ33633778-130C458D-63B3-4441-8E7B-D6B0D25E7E90Q33659976-E4E747E6-372C-4F21-A3E8-3D53FDDEE9C4Q33664711-E9FF6F42-EA68-4BE6-8D82-36A6905A1F3DQ33714159-233A3548-81E2-43CB-86B9-C5561205874FQ33919781-4B7DA70E-93C2-40C0-8A92-A3614E14A9DEQ34441404-8AFE2EF0-45B5-421C-B314-50352B0368CEQ34640800-0AAA3E62-335F-4466-9840-CCD3E7720B97Q34798823-8AA9B16B-7AC9-4514-B994-CD24EA6F8CF4Q35121026-4D6979F1-9440-4440-839B-F7B06407CD69Q35489359-706F253B-9488-4EBE-B217-66DE05D296E4Q35623419-15547EF0-05D5-46A6-9802-BEB322DB329CQ36012034-1438967B-F092-42FE-B8ED-B1AEE359AEA9Q36087937-FA3CDDA2-DD97-4F2B-8CA6-65AA39D22B99Q36093828-F07F6B38-D8CF-4BF7-AADE-A26383E044F0Q36330960-8156D7E4-B8E5-4939-9B4A-DED0CD6BE7F5Q36332951-9643A613-491E-4898-8EEA-8613EE442D04Q36473151-14A04560-9226-48B9-BD15-49B63CDA1F66Q36733981-E68BC772-6B69-4740-BE1F-912D91E1B711Q36934383-A2B84BDA-4FF4-47BB-8EDA-80F557D1C5CBQ37159979-75CF1615-DA37-4AFF-9133-DB820AAC71BCQ37288200-32CEC62C-2546-40C6-8E1E-A4A3F3953631Q37625319-AA6AC181-409B-4173-8529-2D8F63D346D9Q37794395-8ACD43A6-2FCC-452C-AE1E-724326C1683DQ37902077-B344D302-A9B2-4B3C-A4CC-CCBCE6989149Q38730523-D52DCA35-5011-4914-A79E-E3762B0B4F44Q40642266-BA2902FD-D204-4A94-9454-4C8B8028F08FQ41573357-9D5290C7-7103-4259-8F32-0B2D45587859Q41613567-024B990E-AD27-4E54-9A45-03B0B242CEE7Q41832311-A023E70A-0491-4EB0-A794-FF2FEDB5EC42
P2860
Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.
@en
Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.
@nl
type
label
Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.
@en
Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.
@en
Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.
@nl
P2093
P1476
Temporal patterns of cytokine ...... amyotrophic lateral sclerosis
@en
P2093
Brian Gordon
Charles Stewart
Kelly Williamson
Kenneth Hensley
Melinda West
Quentin N Pye
Robert A Floyd
Shenyun Mou
P304
P356
10.1046/J.1471-4159.2002.00968.X
P407
P577
2002-07-01T00:00:00Z